Hepatocellular carcinoma: focus on different aspects of management - Wikidata - wikimedia - TriplyDB

Hepatocellular carcinoma: focus on different aspects of management

Hepatocellular carcinoma: focus on different aspects of management

http://www.wikidata.org/entity/Q35986436

about

Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment Genetic alterations in hepatocellular carcinoma: An update Tree shrew (Tupaia belangeri) as a novel laboratory disease animal model MiR-874 inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting SOX12 Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma.Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo.The Tumor Necrosis Factor-α-308 and -238 Polymorphisms and Risk of Hepatocellular Carcinoma for Asian Populations: A Meta-Analysis Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4)Tegillarca granosa extract Haishengsu induces apoptosis in human hepatocellular carcinoma cell line BEL-7402 via Fas-signaling pathways.Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular Carcinoma The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.Hepatitis B- and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differences Identification of key genes in hepatocellular carcinoma and validation of the candidate gene, cdc25a, using gene set enrichment analysis, meta-analysis and cross-species comparison.miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3)miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1.γ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown.miR-138 suppresses cell proliferation and invasion by inhibiting SOX9 in hepatocellular carcinoma Synthesis of a novel adamantyl nitroxide derivative with potent anti-hepatoma activity in vitro and in vivo.Expression and prognostic significance of golgiglycoprotein73 (GP73) with epithelial-mesenchymal transition (EMT) related molecules in hepatocellular carcinoma (HCC).Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams.Inhibition of mTOR promotes hyperthermia sensitivity in SMMC-7721 human hepatocellular carcinoma cell line.Sialyltransferase ST3GAL6 mediates the effect of microRNA-26a on cell growth, migration, and invasion in hepatocellular carcinoma through the protein kinase B/mammalian target of rapamycin pathway Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma.A novel treatment strategy in hepatocellular carcinoma by down-regulation of histone deacetylase 1 expression using a shRNA lentiviral system.Long non-coding RNA AB209630 suppresses cell proliferation and metastasis in human hepatocellular carcinoma.Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS).ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transition.Complement C1q stimulates the progression of hepatocellular tumor through the activation of discoidin domain receptor 1.Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinoma.Coagulation factor VII gene polymorphisms are not associated with the occurrence or the survival of hepatocellular carcinoma: a report of 37 cases

P2860

Q26747551-19923703-40E1-4C3A-98FD-98BF263CA918 Q28073241-D83CE48E-570E-4877-9F7B-A7859D3E93DF Q33766929-27C31A13-4BF8-4633-B795-5D2B36783682 Q33850052-795847DB-DFD3-4F71-BE22-9F392CCB4F86 Q34207858-B848FCB5-200F-4CED-B581-A24E919D21A3 Q34362849-E4BEAD0A-8B4F-42A4-B619-C5C87E7C9B7B Q34404885-84538A82-8A7C-488E-B5EF-6F95F9C0129B Q34937253-82CACA4F-A8AA-419E-A316-513A355CFEC1 Q35145191-C21D4DCB-EA71-4E39-AFEE-41D1B9939471 Q35278136-8B8B2B0F-7992-4A36-8E5D-59DE749B64D1 Q36085642-80034D31-7700-46F3-A429-607634E27713 Q36185043-4419C821-B19B-4B2A-86F7-7AD002D30192 Q36244298-7D0565D1-DAEB-4C15-85BC-F58379E9EAA2 Q36405369-BAB79C4C-34AE-4228-BB4C-3CC84E770C37 Q36433424-60679BA4-013C-4758-98D1-1FBAC120EDD8 Q36454775-B6AAC351-8D0A-4A05-B282-88D537F07D00 Q36520218-8E079557-61A5-414E-A7F6-69ACFF021FC6 Q36596220-C0BB5568-473E-4106-A872-60D0419FA68A Q36726137-F36C3E50-F73E-470D-8FBD-6125F7CF9B88 Q36730590-AEE5C0D1-6299-477A-9AD8-BFCA98642EC7 Q36964110-88236220-B38E-4BD1-96DF-6C865262B12C Q37077393-D7BA504F-13C8-47A1-81B0-118948AA54A3 Q37585183-70841B1E-3F98-400A-8AAB-E8CAB4EF8A05 Q37697040-75083240-B23E-4231-B478-7542B7C4544A Q38718383-D4404C13-0686-493A-A2D3-CA93ED5F02D5 Q38728098-99B37E8B-11AB-4CF9-8783-BF559C6CCA82 Q39156798-66AC4808-0B1F-4402-AB82-BD68947351A2 Q40832236-BBEFDA85-6D01-4252-8056-AAB82DBEAD0D Q42376378-25EA142F-F794-41BB-9292-B34259271F6C Q48368428-06099B05-1FD1-49CB-86C2-5D34196371CD Q50053815-58FA205A-49A3-42B4-9D75-637206D352F7 Q52646098-DF309906-66BB-4319-BB88-6A34F958C52C Q55500782-381E0AC6-7BFE-469C-A5EA-432CAA2490B3 Q58804954-898FEF1F-6B12-4A4F-9108-3A3B1F54F446

P2860

Hepatocellular carcinoma: focus on different aspects of management

http://www.wikidata.org/entity/Q35986436

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Hepatocellular carcinoma: focus on different aspects of management

@ast

Hepatocellular carcinoma: focus on different aspects of management

@en

type

label

Hepatocellular carcinoma: focus on different aspects of management

@ast

Hepatocellular carcinoma: focus on different aspects of management

@en

prefLabel

Hepatocellular carcinoma: focus on different aspects of management

@ast

Hepatocellular carcinoma: focus on different aspects of management

@en

P1433

Q35986436-DF55DB56-4791-443C-90F2-68B7493714B9

P1476

Q35986436-FA4E8EFB-26BC-4BEC-A8A1-45166C81A6D8

P2093

Q35986436-6899B5BD-D23D-4225-B133-4FE9168F12EF

Q35986436-A335E653-D54B-4CAE-AB07-2B3E4F029EBC

Q35986436-EDBDCFBF-E30C-46D3-867A-BEF045256E50

P2860

Q35986436-09FFDC0C-58BB-4DC9-8D75-9C6C11B4FB52

Q35986436-0C21C330-2F02-4671-8AE5-992B14517195

Q35986436-0D06D93C-6B5D-4F4A-9A59-623D14447D07

Q35986436-10205E2A-17CA-4069-BF29-0E43D36EB1BB

Q35986436-135169AB-0CF9-4160-8F70-D59695F3CBC3

Q35986436-16902972-9C8D-451A-875B-0C0E7DDB8FDA

Q35986436-187337A4-DC81-4306-AA46-03A935FA628D

Q35986436-1963626D-10DD-4D09-B730-01BDDDB3E194

Q35986436-1A3B8B0A-C9F7-44D7-9E41-EEC3A8D665DA

Q35986436-1C1BD798-EE10-4B15-B16D-D6AE6897682D

P304

Q35986436-DF8E1160-75DA-4B05-92D7-C7C4327F0141

P31

Q35986436-C1BCA1C4-AEF9-45A3-B3BF-C9ECB0B1B487

P356

Q35986436-6A4636F1-15BB-457E-9789-53808E066BF0

P478

Q35986436-BF26F3A6-94EE-4603-A231-6BD5EFB1D9D0

P577

Q35986436-410F85C7-8038-4173-8A4A-9E1A835F9047

P5875

Q35986436-B848EADA-87E5-4435-86EC-1FAE208B2314

P698

Q35986436-83EDD547-D274-44FE-A7CA-4570D3E45299

P932

Q35986436-6E4E8A9F-9446-4F40-9F02-6EDBDBB751EC

P356

P1433

P1476

Hepatocellular carcinoma: focus on different aspects of management

@en

P2093

Chen Yuxiang

http://www.w3.org/2001/XMLSchema#string

Sene Waly Raphael

http://www.w3.org/2001/XMLSchema#string

Zhang Yangde

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

Management of hepatocellular carcinoma: An update

Clinical practice. Chronic hepatitis C infection

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor rec

Hepatitis B in China

Hepatocellular carcinoma

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

P304

421673

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5402/2012/421673

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225087405

http://www.w3.org/2001/XMLSchema#string

P698

22655206

http://www.w3.org/2001/XMLSchema#string

P932

3359687

http://www.w3.org/2001/XMLSchema#string